Details
Description
We conducted retrospective public health surveillance using data from 2006 to 2016 in seven integrated delivery systems from FDA’s Sentinel System. We identified pediatric hypertensive patients by clinical and claims-based definitions and compared demographics, baseline profiles and follow-up time profiles.
Materials